Revance Therapeutics, Inc. Contracts & Agreements

146 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Manufacture and Development Agreement dated April 13, 2018 between the Company and Bachem Americas, Inc
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
Amendment No. 2 to the Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc., dated as of...
Merger Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2025
Amendment to the Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of...
Merger Agreements
Revance Therapeutics, Inc.
2024
Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of December 7, 2024
Merger Agreements
Revance Therapeutics, Inc.
2024
Amended and Restated Support Agreement, dated as of December 7, 2024, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and the parties named on Schedule A thereto...
Merger Agreements
Revance Therapeutics, Inc.
2024
Fourth Amendment to Exclusive Distribution Agreement dated June 13, 2024 by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
2024
Fifth Amendment to Exclusive Distribution Agreement dated July 29, 2024 by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
2024
Sixth Amendment to the Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA and Revance Therapeutics, Inc
Distribution Agreements
Revance Therapeutics, Inc.
2024
Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA, Revance Therapeutics, Inc. and Revance Australia Pty. Ltd
Distribution Agreements
Revance Therapeutics, Inc.
2024
Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of August 11, 2024
Merger Agreements
Revance Therapeutics, Inc.
2024
Offer Letter dated September 29, 2022 by and between Revance Therapeutics, Inc. and David Hollander, MD
Revance Therapeutics, Inc.
2024
Offer Letter dated February 21, 2023 by and between Revance Therapeutics, Inc. and Erica Jordan
Revance Therapeutics, Inc.
2024
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
2024
Underwriting Agreement, dated March 4, 2024, by and between the Company and the Underwriter
Underwriting Agreements
Revance Therapeutics, Inc.
2024
Description of Registrants Securities
Revance Therapeutics, Inc.
2024
Revance Therapeutics, Inc. 202
Revance Therapeutics, Inc.
2024
Amendment No. 2 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated February 26, 2024, by and between Revance Therapeutics, Inc. and...
Services Agreements
Revance Therapeutics, Inc.
2024
Separation Agreement dated February 23, 2024 by and between Revance Therapeutics, Inc. and Dustin Sjuts
Separation Agreements
Revance Therapeutics, Inc.
2024
Amended and Restated Executive Severance Benefit Plan
Severance Agreements
Revance Therapeutics, Inc.
2024
License and Service Agreement dated February 8, 2007, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc
License Agreements
Revance Therapeutics, Inc.
2023
First Addendum to the License and Service Agreement dated April 21, 2009, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc
License Agreements
Revance Therapeutics, Inc.
2023
Third Amendment to Lease dated January 13, 2023, by and between Revance Therapeutics, Inc. and 1222 Demonbreun, LP
Lease Agreements
Revance Therapeutics, Inc.
2023
Second Letter Amendment to License Agreement dated
License Agreements
Revance Therapeutics, Inc.
2023
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Form of Restricted Stock Unit Agreement and Grant Notice under Amended and Restated Revance Therapeutics, Inc. 2014 Inducement Plan
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2023
Revance Therapeutics, Inc. 202
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Third Amendment to Exclusive Distribution Agreement dated December 22, 2022, by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Second Amendment to Exclusive Distribution Agreement, dated November 18, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Underwriting Agreement, dated September 12, 2022, by and among the Company and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Separation Agreement dated February 25, 2022 by and between Revance Therapeutics, Inc. and Abhay Joshi
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2022
Third Addendum to License and Service Agreement dated December 9, 2021 between Revance Therapeutics, Inc. and List E, LLC
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Note Purchase Agreement dated March 18, 2022 among Revance Therapeutics, Inc., certain subsidiaries of Revance Therapeutics, Inc., Athyrium Buffalo LP and the purchasers from time...
Note Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2022
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Revance Therapeutics, Inc. 2022 Management Bonus Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated March 14, 2017 between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2022
Separation Agreement
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2022
Second Amendment to Lease, dated July 1, 2021 by and between Revance Therapeutics, Inc and 1222 Demonbreun, LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Commercial Supply Agreement, effective as of April 6, 2021, by and between Revance Therapeutics, Inc. and Lyophilization Services of New England, Inc
Supply Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2021
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Second Addendum to License and Service Agreement, dated March 2, 2021 between Revance Therapeutics, Inc. and List Biological Laboratories, Inc
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Form of Restricted Stock Bonus Agreement and Grant Notice for Revance Therapeutics, Inc. 2014 Equity Incentive Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2021
Form of Restricted Stock Agreement and Grant Notice under Amended and Restated Revance Therapeutics, Inc. 2014 Inducement Plan
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2021
Amendment to Lease, effective as of January 4, 2021, by and between Revance Therapeutics, Inc. and 1222 Demonbreun, LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Revance Therapeutics, Inc. 2021 Management Bonus Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Amendment No. 1 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated December 18, 2020 between Revance Therapeutics, Inc. and Ajinomoto...
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Letter Amendment to the License Agreement dated January 8, 2020 by and between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Office Lease Agreement dated November 19, 2020
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
TN
2020
Executive Employment Agreement effective July 23, 2020 by and between Revance Therapeutics, Inc. and Aubrey Rankin
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Revance Therapeutics, Inc. Amended and Restated 2014 Inducement Plan
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
First Amendment to Exclusive Distribution Agreement
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Fifth Amendment to Lease, dated July 1, 2020, by and between Revance Therapeutics, Inc. and BMR-Pacific Research Center LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Form of Voting Agreement by and between Revance Therapeutics, Inc. and each of the parties named in each agreement therein
Voting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2020
Form of Lock-Up Agreement by and between Revance Therapeutics, Inc. and each of the parties named in each agreement therein
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Loan Agreement, dated May 18, 2020, by and between Revance Therapeutics, Inc. and Hint, Inc
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Description of Registrants Securities
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Revance Therapeutics, Inc. 2020 Management Bonus Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Executive Employment Agreement effective December 1, 2019 and between Revance Therapeutics, Inc. and Dustin Sjuts
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Separation Agreement effective January 8, 2020 by and between Revance Therapeutics, Inc. and Caryn G. McDowell
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Executive Employment Agreement dated February 17, 2020 by and between Revance Therapeutics, Inc. and Dwight Moxie
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Exclusive Distribution Agreement, dated January 10, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Indenture, dated as of February 14, 2020, by and between Revance Therapeutics, Inc. and U.S. Bank National Association, as Trustee
Indenture Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2020
Underwriting Agreement, dated December 4, 2019, by and among the Company and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Amendment #1 to the Collaboration and License Agreement dated August 22, 2019 between Revance Therapeutics, Inc. and Mylan Ireland Ltd
Collaboration Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Separation Agreement effective October 11, 2019 by and between Revance Therapeutics, Inc. and L. Daniel Browne
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Revance Therapeutics, Inc. Executive Severance Benefit Plan, Amended and Restated effective October 13, 2019
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Executive Employment Agreement effective October 13, 2019 by and between Revance Therapeutics, Inc. and Mark J. Foley
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. Executive Severance Benefit Plan, Amended and Restated Effective February 12, 2019
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. 2019 Management Bonus Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Executive Employment Agreement dated November 5, 2018 by and between Revance Therapeutics, Inc. and Tobin Schilke
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Employment Agreement dated November 7, 2018 by and between Revance Therapeutics, Inc. and Cyril Allouche
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
License Agreement, dated December 4, 2018, by and between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2019
Underwriting Agreement, dated January 16, 2019, by and among the Company and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Executive Employment Agreement dated May 1, 2018 by and between Company and Caryn G. McDowell
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2018
Fourth Amendment to Lease, dated May 10, 2018, by and between the Company and BMR-Pacific Research Center LP
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
Collaboration and License Agreement by and between the Company and Mylan Ireland Ltd, dated as of February 28, 2018
Collaboration Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2018
Revance Therapeutics, Inc. Third Amended and Restated Executive Severance Benefit Plan
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2018
Revance Therapeutics, Inc. 2018 Management Bonus Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
Underwriting Agreement, dated December 6, 2017, by and among the Company, the Selling Stockholders and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2017
Executive Employment Agreement by and between the Company and Todd Zavodnick, dated as of September 18, 2017
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2017
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2017
Technology Transfer, Validation and Commercial Fill/Finish Services Agreement
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2017
REVANCE THERAPEUTICS, INC. Second Amended and Restated EXECUTIVE SEVERANCE BENEFIT PLAN
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2017
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2017
REVANCE THERAPEUTICS, INC. 2017 MANAGEMENT BONUS PROGRAM
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2017
REVANCE THERAPEUTICS, INC. $75,000,000 COMMONSTOCK SALES AGREEMENT
Sales Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2016
REVANCE THERAPEUTICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2016
REVANCE THERAPEUTICS, INC. RESTRICTED STOCK BONUS GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
REVANCE THERAPEUTICS, INC. 2016 MANAGEMENT BONUS PROGRAM
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
EXECUTIVE EMPLOYMENT AGREEMENT for Abhay Joshi, PhD, MBA
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2016
SECOND AMENDMENT to DEVELOPMENT AND SUPPLY AGREEMENT between REVANCE THERAPEUTICS, INC. and HOSPIRA WORLDWIDE, INC.
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2015
REVANCE THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. RESTRICTED STOCK BONUS GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
3,250,000 Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Appendix A
Revance Therapeutics, Inc.
Pharmaceuticals
2015
FIRST AMENDMENT TO DEVELOPMENT, MANUFACTURING AND SUPPLY AGREEMENT ___________________________________
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFIT PLAN
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2015
SECOND AMENDMENT TO LOAN AND LEASE AGREEMENT
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE CAPITAL STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2015
REVANCE THERAPEUTICS, INC. $50,000,000 COMMON STOCK SALES AGREEMENT
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
FIRST AMENDMENT TO LOAN ANDLEASE AGREEMENT
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN ADOPTED BY BOARD ON: AUGUST 29, 2014 AS AMENDED ON: SEPTEMBER 17, 2014 TERMINATION DATE: AUGUST 29, 2024
Termination Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
EXECUTIVE EMPLOYMENT AGREEMENT for Arthur P. Bertolino,MD, PhD, MBA
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN ADOPTED BY BOARD ON: AUGUST 26, 2014 TERMINATION DATE: AUGUST 26, 2024
Termination Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
[] Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2014
Appendix A
Revance Therapeutics, Inc.
Pharmaceuticals
2014
REVANCE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
REVANCE THERAPEUTICS, INC. 2014 MANAGEMENT BONUS PROGRAM
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
THIRD AMENDMENT TO LEASE
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
[] Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2014
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 22, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 23, 2014 IPO DATE/EFFECTIVE DATE:[ ],...
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
REVANCE THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 22, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 23, 2014
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
INDEMNITY AGREEMENT [For Officers and Directors Not Affiliated withFunds]
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
REVANCE THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
EXECUTIVE EMPLOYMENT AGREEMENT for L. Daniel Browne
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
EXECUTIVE EMPLOYMENT AGREEMENT for Jacob Waugh, M.D.
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
EXECUTIVE EMPLOYMENT AGREEMENT for Lauren Silvernail
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
EXECUTIVE EMPLOYMENT AGREEMENT for Curtis Ruegg, Ph. D.
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SERIES D PREFERRED STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE CAPITAL STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
WARRANT AGREEMENT To Purchase Shares of Preferred Stock of REVANCE THERAPEUTICS, INC. Dated as of[ ] (the Effective Date)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2013
AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2013
REVANCE THERAPEUTICS, INC. 2002EQUITY INCENTIVE PLAN ADOPTED:OCTOBER 30, 2002 APPROVED BY STOCKHOLDERS:OCTOBER 30, 2002 AMENDED AND RESTATED:FEBRUARY 28, 2003 APPROVED BY...
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2013
REVANCE THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2002 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2013
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:DECEMBER 12, 2012 APPROVED BY THESTOCKHOLDERS: DECEMBER 13, 2012...
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2013
REVANCE THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE AMENDED AND RESTATED 2012 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2013
INDEMNITY AGREEMENT
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2013